Corcept Therapeutics
Pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Learn more
Launch date
Employees
Market cap
AUD5.8b
Enterprise valuation
AUD5.0b (Public information from Sep 2024)
Share price
$40.92 CORT
Menlo Park California (HQ)
Authorizing premium user...